ArticleMolecular therapy : the journal of the American Society of Gene Therapy2022

Dual-aptamer-engineered M1 macrophage with enhanced specific targeting and checkpoint blocking for solid-tumor immunotherapy.

Husun Qian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.